In gastric cancer, NAT10 catalyzes ac4C modification of Mdm2 transcripts, driving imbalance in the Mdm2/p53 regulatory axis by maintaining mRNA epitranscriptomic homeostasis, thereby promoting gastric carcinogenesis. The gene discussed is TP53; the disease is gastric cancer.